Carregant...
Can pimavanserin help patients with Parkinson disease psychosis?
Pimavanserin is a first-in-class selective serotonin 5-HT(2A) receptor inverse agonist approved for the treatment of Parkinson disease psychosis. This article discusses pimavanserin’s mechanism of action, which patients are appropriate candidates for therapy, adverse reactions, and appropriate dosin...
Guardat en:
| Publicat a: | JAAPA |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6764088/ https://ncbi.nlm.nih.gov/pubmed/30589736 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/01.JAA.0000547757.46299.3d |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|